Ligand binding and modulation of cyclic AMP levels depend on the chemical nature of residue 192 of the human cannabinoid receptor 1

Journal of Neurochemistry

Volumn 70, Issue 1, 1998, Pages 366-373

  Chin, Chen Ni ^a   Lucas Lenard, Jean ^a   Abadji, Vasiliki ^a   Kendall, Debra A ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Adenylyl cyclase; Aminoalkylindole; Bicyclic cannabinoid; Cannabinoid receptor; Cyclic AMP; G protein coupled receptor

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ADENYLATE CYCLASE; CANNABINOID RECEPTOR; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; TETRAHYDROCANNABINOL;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALIA; CANNABIS SATIVA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0031972779     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70010366.x     Document Type: Article

References (33)

1. Abadji V., Lin S., Taha G., Griffin G., Stevenson L. A., Pertwee R. G., and Makriyannis A. (1994) (R)-Methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J. Med. Chem. 37, 1889-1893.
2. Abood M. E., Ditto K. E., Noel M. A., Showalter V. M., and Tao Q. (1997) Isolation and expression of a mouse CB1 cannabinoid receptor gene. Biochem. Pharmacol. 53, 207-214.
3. Baldwin J. M. (1993) The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12, 1693-1703.
4. Bouaboula M., Poinot-Chazel C., Bourrie B., Canat X., Calandra B., Rinaldi-Carmona M., Le Fur G., and Casellas P. (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J. 312, 637-641.
5. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72, 248-254.
6. Bramblett R. D., Panu A. M., Ballesteros J. A., and Reggio P. H. (1995) Construction of a 3D model of the cannabinoid CB1 receptor: determination of helix ends and helix orientation. Life Sci. 56, 1971-1982.
7. Deadwyler S. A., Hampson R. E., and Childers S. R. (1995) Functional significance of cannabinoid receptors in brain, in Cannabinoid Receptors (Pertwee R. G., ed), pp. 205-231. Academic Press, San Diego.
8. Devane W. A., Francis A. D. III, Johnson M. R., Melvin L. S., and Howlett A. C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34, 605-613.
9. Devane W. A., Hanuš L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
10. Dewey W. L. (1986) Cannabinoid pharmacology. Pharmacol. Rev. 38, 151-178.
11. Felder C. C., Veluz J. S., Williams H. L., Briley E. M., and Matsuda L. A. (1992) Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42, 838-845.
12. Fong T. M., Cascieri M. A., Yu H., Bansal A., Swain C., and Strader C. D. (1994) Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345. Nature 362, 350-353.
13. Fraser C. M., Wang C.-D., Robinson D. A., Gocayne J. D., and Venter J. C. (1989) Site directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. Mol. Pharmacol. 36, 840-847.
14. Gérard C. M., Mollereau C., Vassart G., and Parmentier M. (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279, 129-134.
15. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29, 307-313.
16. Huffman J. W., Yu S., Showalter V., Abood M. E., Bramblett R. D., and Reggio P. H. (1996) Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor. J. Med. Chem. 39, 3875-3877.
17. Jansen E. M., Haycock D. A., Ward S. J., and Seybold V. S. (1992) Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res. 575, 93-102.
18. Kosugi S., Mori T., and Shenker A. (1996) The role of Asp 578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. J. Biol. Chem. 271, 31813-31817.
19. Mackie K. and Hille B. (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 89, 3825-3829.
20. Martin B. R., Thomas B. F., and Razdan R. K. (1995) Structural requirements for cannabinoid receptor probes, in Cannabinoid Receptors (Pertwee R. G., ed), pp. 36-79. Academic Press, San Diego.
21. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., and Bonner T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
22. Mountjoy K. G., Robbins L. S., Mortrud M. T., and Cone R. D. (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251.
23. Munro S., Thomas K. L., and Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
24. Noda K., Saad Y., Kinoshita A., Boyle T. P., Graham R. M., Husain A., and Kamik S. S. (1995) Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms. J. Biol. Chem. 270, 2284-2289.
25. Razdan R. K. (1986) Structure-activity relationships in cannabinoids. Pharmacol. Rev. 38, 75-149.
26. Reggio P. H. (1987) Molecular determinants for cannabinoid activity: refinement of a molecular reactivity template, in NIDA Research Monograph, Vol. 79 (Rapaka R. S. and Makriyannis A., eds), pp. 82-95. U.S. Government Printing Office, Washington, D.C.
27. Sakmar T. P., Franke R. R., and Khorana H. G. (1989) Glutamic acid-113 serves as the retinylidene Schiff base counterion in bovine rhodopsin. Proc. Natl. Acad. Sci. USA 86, 8309-8313.
28. 2-adrenergic receptor. J. Biol. Chem. 268, 4625-4636.
29. Sanger F., Nicklen S., and Coulson A. R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
30. Semus S. F. and Martin B. R. (1990) A computergraphic investigation into the pharmacological role of the THC-cannabinoid phenolic moiety. Life Sci. 46, 1781-1785.
31. Song Z.-H. and Bonner T. I. (1996) A lysine residue of the cannabinoid receptor is critical to receptor recognition by several agonists but not WIN 55,212-2. Mol. Pharmacol. 49, 891-896.
32. Xie X.-Q., Eissenstat M., and Makriyannis A. (1995) Common cannabimimetic pharmacophoric requirements between aminoalkyl indoles and classical cannabinoids. Life Sci. 56, 1963-1970.
33. Xie X.-Q., Melvin L. S., and Makriyannis A. (1996) The conformational properties of the highly selective cannabinoid receptor ligand CP-55,940. J. Biol. Chem. 271, 10640-10647.